Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Share buy back, merger & licensing thoughts....
1
Mar 28, 2008 06:30PM
2
Mar 28, 2008 06:30PM
3
Mar 28, 2008 09:32PM

If PTSC's top priority is a merger or acquisition, then I believe they will not be interested in buying back shares at this time. I believe they will keep as much cash on hand for the merger or aquisition.

I believe a priority for PTSC is to get off this exchange. Probably the easiest way to get there is to merge or acquire a company already on the NASDAQ or New York stock exchange. My guess on this last weeks SP performance was largely due to Market Makers taking advantage of the closeness of the Q3 report to draw in investors watching closely on the sidelines for a sign that the build-up to Q3 report had begun.

I also believe that the reason we have not heard of any licensing recently is that PTSC is saving a group of licenses for release just after the Q3 report to boost investor confidence and to try and curb as much sell off as possible.

I also believe the story of PTSC's success will finally be told after the Q to attract new investors.

All this is my wishful thinking.

All the best,

Steve

1
Mar 30, 2008 05:13PM
5
Mar 31, 2008 03:51AM
3
Mar 31, 2008 08:07AM
2
Mar 31, 2008 08:24AM

Mar 31, 2008 09:37AM

Mar 31, 2008 09:42AM
Share
New Message
Please login to post a reply